ArticleJournal of medicinal chemistry2014

Asymmetric binding to NS5A by daclatasvir (BMS-790052) and analogs suggests two novel modes of HCV inhibition.

James H Nettles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.